公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA取消

61 记录

产品持有公司班级有效性
yellow fever10338930071EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII01/02/2035
anti yellow fever virus IIFT10338930076EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/05/2035
ANTI-HSV 1/2 IGM10338930090EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII24/03/2034
ANTI-HSV 1/2 IGG10338930097EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII10/06/2034
Rubéola IgG em Líquor10338930106EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Rubéola IgG10338930107EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Rubéola Avidez IgG10338930109EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Rubéola IgM10338930112EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Anti-HSV-1/2 IgG em Líquor10338930119EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII15/09/2034
Bordetella pertussis (IgG)10338930124EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Dengue virus (IgG)10338930125EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Bordetella pertussis (IgM)10338930129EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Varicella zoster IgM10338930136EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII08/12/2034
Sarampo IgM10338930138EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII08/12/2034
Varicella zoster IgG10338930139EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII08/12/2034
Sarampo IgG10338930143EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII15/12/2034
Parvovírus B19 IgG10338930160EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/01/2035
Parvovírus B19 IgM10338930161EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/01/2035
Vírus da Influenza A IgG10338930169EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII02/02/2035
Anti-HSV-2 (gG2) IgG10338930178EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII02/03/2035
Anti-Schistosoma mansoni IgG10338930196EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/10/2028
Anti-Mayaro vírus IgM10338930199EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII28/01/2029
Anti-Mayaro vírus IgG10338930200EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII28/01/2029
Anti-Hepatite E (HEV) IgM10338930223EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/07/2029
Anti-SARS-CoV-2 ELISA IgA10338930226EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII03/04/2030

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家